OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Equity Capital Raises
Equity Transaction Chart
Viridian publishes weekly data on equity capital raises in the Cannabis/CBD/Psychedelic industries. This data includes information about the company issuing equity (public/private, state/country location), deal size, deal structure, pricing, share information, deal implied valuation, and warrant information.
Week ended 08/30/2024
Week ended 08/30/2024
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Equity Commentary
Week ended 08/30/2024
Equity Raises:
- On August 26, 2024, ZYUS Life Sciences (ZYUS: TSX), a Canadian Life Science company focused on the development and commercialization of cannabinoid-based drugs for pain management, closed a private placement of equity units for gross proceeds of $2.47M.
- 5M units per sold at $.70 per unit
- Each unit consisted of one common share and one two-year warrant with an exercise premium of 37%.
- The majority of the proceeds will be used to repay debt owing to the Company’s President and CEO and an entity controlled by him.
- The company’s proforma free cash flow adjusted current ratio of -.18x suggests that it will need to raise more capital in the next several quarters.
Public vs. Private Raises:
- All three companies that raised capital this week are public. All three trade in Canada (two on the TSX and one on the Cboe). Two trade in the U.S. on OTC.
Equity vs. Debt Cap Raises:
- Equity accounted for 35.6% of the week’s capital raise activity.
Week ended 08/30/2024
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Weekly Valuation Tracker
Viridian highlights a specific industry sector and provides a deep dive into valuation metrics and comparable company valuations for public companies operating in that sector. The Weekly Valuation Tracker provides proprietary, actionable valuation data.
- Week ended 08/30/2024
This week’s valuation tracker focuses on the 7 U.S. MSOs with market cap over $500M in the Viridian Value Tracker database in gauge the valuation impact of the 2nd earnings that have been released so far, Green Thumb (GTII: CSE), Curaleaf (CURA: CSE), and Trulieve.
- Week ended 08/30/2024
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Viridian publishes weekly insights on equity capital raises in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful equity transactions of that week, and commentary on market conditions, equity deal structures and investor groups.